Industry leading journal Genome Web has recently published an article on Syantra's fast path to commercialization in 2026.

Read it in detail here: https://www.genomeweb.com/cancer/syantra-nearing-commercialization-early-breast-cancer-test-large-scale-study

‍

NOTE: Genome Web login required

‍

Share this post

More from our archives

Announcements
August 10, 2026

Study Finds Blood-Based Breast Cancer Detection Can Create Value for Patients and Healthcare Systems

CALGARY, AB. - Today, Syantra, a liquid biopsy platform and innovation company that is changing the way cancer is detected, starting with Syantra DX™ Breast Cancer...
Read more
Announcements
December 9, 2025

Vincere Cancer Center Begins Recruitment for Clinical Studies of Pioneering Breast Cancer Screen for Women at High Risk

CALGARY, AB. - Today, Syantra, a liquid biopsy platform and innovation company that is changing the way cancer is detected, starting with Syantra DX™ Breast Cancer...
Read more
Announcements
November 3, 2025

Syantra and Alamo Breast Cancer Foundation launch first-of-its-kind partnership

CALGARY, AB. - Today, Syantra, a liquid biopsy platform and innovation company that is changing the way cancer is detected, starting with Syantra DX™ Breast Cancer...
Read more
View all